The Vision Is Clear: Listen To Merck And Invest In Microcap KalVista Pharmaceuticals – Seeking Alpha
Seeking AlphaI took notice of the deal because it was substantial for a micro-cap stock trading at a valuation under $100M. Based on meeting various milestones Merck signed on to pay up to $760M and tiered royalties for candidates commercialized for DME … and more …read more Source:: MicroCap Stock News From Google News
from WordPress http://ift.tt/2yrwHQ3
via IFTTT
from WordPress http://ift.tt/2yrwHQ3
via IFTTT
Post A Comment
No comments :